Asia’s Premier Forum for Next-Generation Antibody Engineering: Bridging the Gap Between Innovation and Clinical Reality
Join the international antibody community to explore the future of therapeutic design. From AI-enabled discovery to breakthrough oral delivery and advanced ADC platforms. Experience the latest R&D advances and clinical data dedicated to fast-tracking complex biologics toward Global commercial success.
Kyoto Calling🎌: AET Asia 2026 Agenda Released Soon!
Our 2026 program is almost here. Register your interest below for an exclusive first look at the agenda.
The 2026 Scientific Agenda: Pushing the Boundaries of Biologics
Explore the technical milestones and clinical breakthroughs defining the future of antibody engineering across our three core pillars of innovation.
Digital Discovery & AI-Powered Engineering
- Intelligent Molecular Design: Utilising machine learning technologies to solve clinical problems through clever molecular design and architectures.
- High-Speed Discovery Platforms: Leveraging novel models and mammalian display for the rapid generation and redesign of therapeutics at a rapid pace.
- Precision Immunomics: Harnessing large-scale repertoire analysis and high-throughput sequencing to identify disorder-specific leads and targets.
- The Digital Workflow: Integrating data, NGS, and predictive biophysics to solve developability crises early in the process.
Next-Gen Modalities & Breakthrough Delivery Systems
- Breaking the Delivery Barrier: Engineering "impossible" solutions for the oral delivery of complex biologics and developing shuttles to cross the blood-brain barrier.
- Multispecific & Nanobody Architectures: Leveraging the structural flexibility and small size of VHH domains to pack increased functionality into complex therapies.
- Emerging Therapeutic Modalities: Advancing the future of extracellular degraders, PROTACs, and context-dependent binding molecules designed for localized activity.
- Intracellular Targeting: Exploring the next frontier of engineering to reach previously undruggable targets within the intracellular space.
Conjugate Innovation, Safety & The Path to Clinic
- The ADC Frontier: Advancing site-specific conjugation and stable linker technologies to optimize the therapeutic window for solid tumours.
- Translational Safety & PK/PD: Utilizing humanized mouse models and spatial omics to predict complex immune responses and risks pre-clinic.
- The Fc Resurgence: Engineering effector function to "sculpt" the tumour microenvironment for enhanced therapeutic efficacy.
- Design for Manufacturability: Applying AI-driven triage and practical engineering assessments to ensure complex formats are optimized for large-scale clinical production.
Learn from Global Leaders Driving the Next Wave of Antibody Innovation
Gain exclusive insights from the industry's most respected pioneers as they reveal the engineering strategies and clinical data driving the next generation of antibody therapeutics. Our early-confirmed keynotes represent the pinnacle of global biologics innovation, offering a unique opportunity to learn from the architects of today’s most complex and successful molecules.
Taichi Kuramochi, Ph.D. Head of Biologics Discovery, Chugai Pharmaceutical
Hear directly from the architect behind Chugai’s most innovative engineering, including "Switch-Ig" technologies and the rational design of first-in-class multispecifics for autoimmune diseases like Celiac Disease.
Jais Bjelke, Ph.D., Principal Scientist, Novo Nordisk
Discover how Novo Nordisk is "Engineering the Impossible" with a deep dive into the design and clinical progress of the world’s first oral VHH-based antibody for haemophilia.
In 2025 we brought you:
+
Antibody Experts
+
Leading Speakers
+
Hours of Scientific Content
Hours
of Networking
See who joined us at last year's meeting, before the full 2026 cohort drops soon!
Meet the brilliant minds who shared their expertise at AET Asia 2025. The 2026 Expert Speaker Line-Up will be released very soon...
New Data, Case Studies & Networking with Antibody Experts
What to expect?
"An excellent, well organized meeting bringing together a diverse group of researchers focused on antibody discovery, development and manufacture, providing very good opportunities to connect with new people and old friends. I especially enjoyed the breadth of the talks, in a single track format so I learned from a wider range of topics that I would not otherwise have heard in detail."
Returning to Kyoto, we're uniting scientists, researchers, and thought leaders from across the antibody ecosystem to deliver groundbreaking research with a specialized focus on ADCs and bispecifics. Connect with the right partners and accelerate your success in this rapidly evolving field.
Who will you meet?
You don't have to choose between quality and quantity when it comes to Antibody Engineering & Therapeutics Asia. We deliver on both.
The most innovative. The most specialized. With the most biopharma leaders in Asia. Need we say more?
Companies already registered include, Chugai Pharmaceutical, Daiichi Sankyo, Argenx, Axcynsis Therapeutics, Genmab and more.
Strategic Networking Made Simple
Enable ConnectMe and arrive in Kyoto with a diary full of meetings with antibody researchers, developers, and potential collaborators from across the global therapeutic antibody community.
The platform allows you to browse attendee profiles, send meeting requests, and schedule appointments before and during the event, ensuring you maximize every networking opportunity.
Poster Showcase
Present your groundbreaking antibody research at our dynamic Poster Session. Connect with industry experts and academic pioneers in this focused forum designed for meaningful scientific exchange. Scheduled presentation times allow for in-depth discussions with peers and thought leaders.
Submit your abstract today and gain visibility for your innovations in antibody engineering.
Antibody Science Takes Center Stage in Kyoto
Join us in Kyoto, where cutting-edge antibody research converges in a city of remarkable heritage. This ancient capital provides a unique setting where scientific innovation thrives amid historic temples and gardens. Discover new perspectives as you connect with global experts in antibody engineering against the backdrop of Japan's cultural treasure.
Supercharge Your Experience
Maximize your conference value with our intensive Pre-Conference Workshop Day!
Join us for two expert-led sessions that take you from fundamentals to cutting-edge applications. The morning workshop explores essential antibody engineering principles, while the afternoon session reveals the exciting world of bispecific and multispecific antibodies. This is the perfect opportunity to expand your knowledge and networking with peers before the main event begins.
Engage Quality Decision-Makers at Antibody Engineering & Therapeutics Asia!
Whether you're looking to generate quality leads, showcase thought leaders, or reinforce your brand, collaborate with us to identify custom sponsorship opportunities to help you reach your business objectives.
Contact Blake Shuka to learn more at BShuka@informaconnectls.com
Watch the 2025 Highlights
Take a peek at the key moments, groundbreaking presentations, and vibrant networking sessions from Antibody Engineering & Therapeutics Asia. Back again for 2026, now’s your chance to see why this is the premier event driving antibody innovation in the Asia-Pacific region.